What Causes a Broken Heart—Molecular Insights into Heart Failure
Authors:
- 1 January 2010
- book chapter
- Published by Elsevier
- Vol. 284, 113-179
Abstract
No abstract availableKeywords
This publication has 373 references indexed in Scilit:
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategiesPharmacology & Therapeutics, 2010
- Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2Basic Research in Cardiology, 2010
- Ca2+/Calmodulin-dependent Protein KinasesCellular and Molecular Life Sciences, 2008
- Insulin signaling pathways and cardiac growthJournal of Molecular and Cellular Cardiology, 2008
- T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin–NFAT3 activation as well as L-type Ca2+ channel blockersLife Sciences, 2008
- Prevention of Cardiac Hypertrophy and Heart Failure by Silencing of NF-κBJournal of Molecular Biology, 2008
- Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophyJournal of Molecular and Cellular Cardiology, 2007
- Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteinsJournal of Molecular and Cellular Cardiology, 2007
- β-adrenergic receptors signaling and heart failure in mice, rabbits and humans☆Journal of Molecular and Cellular Cardiology, 2006
- Inositol 1,4,5-trisphosphate induces calcium release from sarcoplasmic reticulum of skeletal muscleNature, 1985